Mettler-Toledo International Inc. (MTD) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | (m) | |
| Revenue | 4.13B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 208.01M USD | Research and Development Expense |
| Selling, general and administration | 1.03B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.13B | (m) | $208.01M | $1.03B | (m) |
| 2026-03-31 | (m) | $4.09B | (m) | $204.30M | $1.01B | (m) |
| 2025-12-31 | (m) | $4.03B | (m) | $199.37M | $998.31M | (m) |
| 2025-09-30 | (m) | $3.94B | (m) | $196.83M | $975.83M | (m) |
| 2025-06-30 | (m) | $3.87B | (m) | $192.80M | $956.21M | (m) |
| 2025-03-31 | (m) | $3.83B | (m) | $189.29M | $944.71M | (m) |
| 2024-12-31 | (m) | $3.87B | (m) | $189.36M | $936.30M | (m) |
| 2024-09-30 | (m) | $3.76B | (m) | $185.74M | $922.39M | (m) |
| 2024-06-30 | (m) | $3.75B | (m) | $184.75M | $911.06M | (m) |
| 2024-03-31 | (m) | $3.79B | (m) | $186.22M | $903.86M | (m) |
| 2023-12-31 | (m) | $3.79B | (m) | $185.28M | $904.11M | (m) |
| 2023-09-30 | (m) | $3.91B | (m) | $184.79M | $908.26M | (m) |
| 2023-06-30 | (m) | $3.95B | (m) | $182.79M | $924.17M | (m) |
| 2023-03-31 | (m) | $3.95B | (m) | $179.57M | $937.79M | (m) |
| 2022-12-31 | (m) | $3.92B | (m) | $177.12M | $938.46M | (m) |
| 2022-09-30 | (m) | $3.90B | (m) | $176.79M | $953.32M | (m) |
| 2022-06-30 | (m) | $3.87B | (m) | $174.94M | $960.70M | (m) |
| 2022-03-31 | (m) | $3.81B | (m) | $173.52M | $957.54M | (m) |
| 2021-12-31 | (m) | $3.72B | (m) | $169.77M | $943.98M | (m) |
| 2021-09-30 | (m) | $3.62B | (m) | $164.02M | $927.90M | (m) |
| 2021-06-30 | (m) | $3.47B | (m) | $156.40M | $892.14M | (m) |
| 2021-03-31 | (m) | $3.24B | (m) | $144.99M | $843.23M | (m) |
| 2020-12-31 | (m) | $3.09B | (m) | $140.10M | $820.22M | (m) |
| 2020-09-30 | (m) | $2.99B | (m) | $135.54M | $800.57M | (m) |
| 2020-06-30 | (m) | $2.94B | (m) | $136.90M | $798.42M | (m) |
| 2020-03-31 | (m) | $2.98B | (m) | $142.28M | $813.50M | (m) |
| 2019-12-31 | (m) | $3.01B | (m) | $143.95M | $819.18M | (m) |
| 2019-09-30 | (m) | $2.98B | (m) | $144.85M | $814.12M | (m) |
| 2019-06-30 | (m) | $2.96B | (m) | $143.68M | $813.74M | (m) |
| 2019-03-31 | (m) | $2.95B | (m) | $142.41M | $816.55M | (m) |
| 2018-12-31 | (m) | $2.94B | (m) | $141.07M | $812.80M | (m) |
| 2018-09-30 | (m) | $2.90B | (m) | $138.15M | $810.30M | (m) |
| 2018-06-30 | (m) | $2.86B | (m) | $135.51M | $814.88M | (m) |
| 2018-03-31 | (m) | $2.79B | (m) | $132.78M | $802.48M | (m) |
| 2017-12-31 | (m) | $2.73B | (m) | $129.26M | $787.46M | (m) |
| 2017-09-30 | (m) | $2.66B | (m) | $126.88M | $770.83M | (m) |
| 2017-06-30 | (m) | $2.61B | (m) | $124.54M | $753.59M | (m) |
| 2017-03-31 | (m) | $2.56B | (m) | $122.39M | $747.87M | (m) |
| 2016-12-31 | (m) | $2.51B | (m) | $119.97M | $732.62M | (m) |
| 2016-09-30 | (m) | $2.47B | (m) | $120.92M | $721.82M | (m) |
| 2016-06-30 | (m) | $2.43B | (m) | $120.50M | $709.68M | (m) |
| 2016-03-31 | (m) | $2.40B | (m) | $119.59M | $696.69M | (m) |
| 2015-12-31 | (m) | $2.40B | (m) | $119.08M | $700.81M | (m) |
| 2015-09-30 | (m) | $2.42B | (m) | $119.29M | $710.18M | (m) |
| 2015-06-30 | (m) | $2.44B | (m) | $119.93M | $721.13M | (m) |
| 2015-03-31 | (m) | $2.47B | (m) | $122.26M | $729.43M | (m) |
| 2014-12-31 | (m) | $2.49B | (m) | $123.30M | $728.58M | (m) |
| 2014-09-30 | (m) | $2.47B | (m) | $122.57M | $721.68M | (m) |
| 2014-06-30 | (m) | $2.44B | (m) | $121.27M | $708.62M | (m) |
| 2014-03-31 | (m) | $2.41B | (m) | $118.14M | $698.95M | (m) |
| 2013-12-31 | (m) | $2.38B | (m) | $116.35M | $692.79M | (m) |
| 2013-09-30 | (m) | $2.35B | (m) | $113.75M | $688.38M | (m) |
| 2013-06-30 | (m) | $2.34B | (m) | $112.60M | $685.95M | (m) |
| 2013-03-31 | (m) | $2.33B | (m) | $111.56M | $682.50M | (m) |
| 2012-12-31 | (m) | $2.34B | (m) | $112.53M | $684.03M | (m) |
| 2012-09-30 | (m) | $2.33B | (m) | $114.64M | $693.01M | (m) |
| 2012-06-30 | (m) | $2.36B | (m) | $116.82M | $707.83M | (m) |
| 2012-03-31 | (m) | $2.35B | (m) | $118.45M | $709.89M | (m) |
| 2011-12-31 | (m) | $2.31B | (m) | $116.14M | $703.63M | (m) |
| 2011-09-30 | (m) | $2.25B | (m) | $112.49M | $684.07M | (m) |
| 2011-06-30 | (m) | $2.14B | (m) | $107.41M | $643.54M | (m) |
| 2011-03-31 | (m) | $2.05B | (m) | $100.91M | $615.09M | (m) |
| 2010-12-31 | (m) | $1.97B | (m) | $97.03M | $588.73M | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.73B | (m) | $89.69M | $505.18M | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.97B | (m) | $102.28M | $579.81M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |